These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 19288012)
1. Enhanced effects of PPARgamma ligands and RXR selective retinoids in combination to inhibit migration and invasiveness in cancer cells. Papi A; Rocchi P; Ferreri AM; Guerra F; Orlandi M Oncol Rep; 2009 Apr; 21(4):1083-9. PubMed ID: 19288012 [TBL] [Abstract][Full Text] [Related]
2. RXRgamma and PPARgamma ligands in combination to inhibit proliferation and invasiveness in colon cancer cells. Papi A; Rocchi P; Ferreri AM; Orlandi M Cancer Lett; 2010 Nov; 297(1):65-74. PubMed ID: 20510503 [TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of retinoic acid and IIF on growth, migration and invasiveness in the U87MG human glioblastoma cell line. Papi A; Bartolini G; Ammar K; Guerra F; Ferreri AM; Rocchi P; Orlandi M Oncol Rep; 2007 Oct; 18(4):1015-21. PubMed ID: 17786368 [TBL] [Abstract][Full Text] [Related]
4. Combined low doses of PPARgamma and RXR ligands trigger an intrinsic apoptotic pathway in human breast cancer cells. Bonofiglio D; Cione E; Qi H; Pingitore A; Perri M; Catalano S; Vizza D; Panno ML; Genchi G; Fuqua SA; Andò S Am J Pathol; 2009 Sep; 175(3):1270-80. PubMed ID: 19644018 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of ERK activity enhances the cytotoxic effect of peroxisome proliferator-activated receptor γ (PPARγ) agonists in HeLa cells. Chang HK; Kim DS; Chae JJ; Kim M; Myong JP; Lee KH; Lee MW; Park TC Biochem Biophys Res Commun; 2017 Jan; 482(4):843-848. PubMed ID: 27888104 [TBL] [Abstract][Full Text] [Related]
6. Retinoid X receptor and peroxisome proliferator-activated receptor-gamma agonists cooperate to inhibit matrix metalloproteinase gene expression. Burrage PS; Schmucker AC; Ren Y; Sporn MB; Brinckerhoff CE Arthritis Res Ther; 2008; 10(6):R139. PubMed ID: 19046432 [TBL] [Abstract][Full Text] [Related]
7. PPARgamma and RXRgamma ligands act synergistically as potent antineoplastic agents in vitro and in vivo glioma models. Papi A; Tatenhorst L; Terwel D; Hermes M; Kummer MP; Orlandi M; Heneka MT J Neurochem; 2009 Jun; 109(6):1779-90. PubMed ID: 19457135 [TBL] [Abstract][Full Text] [Related]
8. Cell death is induced by ciglitazone, a peroxisome proliferator-activated receptor γ (PPARγ) agonist, independently of PPARγ in human glioma cells. Lee MW; Kim DS; Kim HR; Kim HJ; Yang JM; Ryu S; Noh YH; Lee SH; Son MH; Jung HL; Yoo KH; Koo HH; Sung KW Biochem Biophys Res Commun; 2012 Jan; 417(1):552-7. PubMed ID: 22177955 [TBL] [Abstract][Full Text] [Related]
9. A retinoid X receptor (RXR)-selective retinoid reveals that RXR-alpha is potentially a therapeutic target in breast cancer cell lines, and that it potentiates antiproliferative and apoptotic responses to peroxisome proliferator-activated receptor ligands. Crowe DL; Chandraratna RA Breast Cancer Res; 2004; 6(5):R546-55. PubMed ID: 15318936 [TBL] [Abstract][Full Text] [Related]
10. Specific thiazolidinediones inhibit ovarian cancer cell line proliferation and cause cell cycle arrest in a PPARγ independent manner. Al-Alem L; Southard RC; Kilgore MW; Curry TE PLoS One; 2011 Jan; 6(1):e16179. PubMed ID: 21283708 [TBL] [Abstract][Full Text] [Related]
11. Synergistic effects of RXR alpha and PPAR gamma ligands to inhibit growth in human colon cancer cells--phosphorylated RXR alpha is a critical target for colon cancer management. Yamazaki K; Shimizu M; Okuno M; Matsushima-Nishiwaki R; Kanemura N; Araki H; Tsurumi H; Kojima S; Weinstein IB; Moriwaki H Gut; 2007 Nov; 56(11):1557-63. PubMed ID: 17604322 [TBL] [Abstract][Full Text] [Related]
12. Anti-invasive effects and proapoptotic activity induction by the rexinoid IIF and valproic acid in combination on colon cancer cell lines. Papi A; Ferreri AM; Guerra F; Orlandi M Anticancer Res; 2012 Jul; 32(7):2855-62. PubMed ID: 22753748 [TBL] [Abstract][Full Text] [Related]
13. PPARγ and RXR ligands disrupt the inflammatory cross-talk in the hypoxic breast cancer stem cells niche. Papi A; De Carolis S; Bertoni S; Storci G; Sceberras V; Santini D; Ceccarelli C; Taffurelli M; Orlandi M; Bonafé M J Cell Physiol; 2014 Nov; 229(11):1595-606. PubMed ID: 24604522 [TBL] [Abstract][Full Text] [Related]
14. [Pro-apoptotic effect of ciglitazone in leukemic HL-60 cells via PPARγ and P38 MAPK signaling pathway]. Liu JJ; Liu WD; Liu XD; Raj-Shrestha P; Liu PQ; Huang HQ; Wu CB; Wang CZ; Xu Y; Xiao RZ; Lin DJ; Huang RW Zhonghua Yi Xue Za Zhi; 2010 Aug; 90(32):2270-4. PubMed ID: 21029675 [TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor gamma ligand inhibits cell growth and invasion of human pancreatic cancer cells. Hashimoto K; Ethridge RT; Evers BM Int J Gastrointest Cancer; 2002; 32(1):7-22. PubMed ID: 12630765 [TBL] [Abstract][Full Text] [Related]
16. EGFR inhibition by (-)-epigallocatechin-3-gallate and IIF treatments reduces breast cancer cell invasion. Farabegoli F; Govoni M; Spisni E; Papi A Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28465354 [TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor-γ inhibits pancreatic cancer cell invasion and metastasis via regulating MMP-2 expression through PTEN. Li Y; Zhang DW; Lin DQ; Cao LQ Mol Med Rep; 2015 Oct; 12(4):6255-60. PubMed ID: 26299428 [TBL] [Abstract][Full Text] [Related]
18. Activation of peroxisome proliferator-activated receptor-gamma induces apoptosis on acute promyelocytic leukemia cells via downregulation of XIAP. Liu JJ; Guo YW; Fang ZG; Si XN; Wu XY; Liu PQ; Lin DJ; Xiao RZ; Xu Y; Wang CZ; Li XD; He Y; Huang RW Int J Mol Med; 2009 Nov; 24(5):623-32. PubMed ID: 19787196 [TBL] [Abstract][Full Text] [Related]
19. Combinational effect of PPARγ agonist and RXR agonist on the growth of SGC7901 gastric carcinoma cells in vitro. Liu Y; Zhu ZA; Zhang SN; Mou J; Liu L; Cui T; Pei DS Tumour Biol; 2013 Aug; 34(4):2409-18. PubMed ID: 23605322 [TBL] [Abstract][Full Text] [Related]
20. Ligand Activity of Group 15 Compounds Possessing Triphenyl Substituent for the RXR and PPARγ Nuclear Receptors. Hiromori Y; Ido A; Aoki A; Kimura T; Nagase H; Nakanishi T Biol Pharm Bull; 2016; 39(10):1596-1603. PubMed ID: 27725436 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]